SINGAPORE healthtech startup Biofourmis, headquartered in Boston, has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its patient data-monitoring solution,...

HEALTHTECH startup Biofourmis has clinched US$35 million in a Series B equity financing round led by Sequoia India, part of Sequoia Capital, and MassMutual Ventures SEA, the venture fund of...

BIOFOURMIS, a Singapore-based health-tech startup, has received clearance from the US Food and Drug Association (FDA) for its cloud-based software, RhythmAnalytics, which aids healthcare...